The store will not work correctly when cookies are disabled.
N-(4-Bromophenyl)-2-methylimidazo[1,2-a]pyridine-3-carboxamide
ID: ALA3310316
PubChem CID: 84291073
Max Phase: Preclinical
Molecular Formula: C15H12BrN3O
Molecular Weight: 330.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nc2ccccn2c1C(=O)Nc1ccc(Br)cc1
Standard InChI: InChI=1S/C15H12BrN3O/c1-10-14(19-9-3-2-4-13(19)17-10)15(20)18-12-7-5-11(16)6-8-12/h2-9H,1H3,(H,18,20)
Standard InChI Key: DJRFYKRGDWLFKX-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
3.7778 -3.8518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0634 -4.2643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0634 -5.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7778 -5.5018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4923 -5.0893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4923 -4.2643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9494 -3.0449 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7699 -2.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1054 -3.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9124 -3.8838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1673 -4.6685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4957 -3.3005 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1824 -2.2442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2926 -3.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8760 -2.9306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6729 -3.1442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8864 -3.9410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3031 -4.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5062 -4.3109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6833 -4.1546 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 1 0
8 9 2 0
6 9 1 0
1 7 2 0
10 11 2 0
10 12 1 0
9 10 1 0
8 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 2 0
17 20 1 0
12 14 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.19 | Molecular Weight (Monoisotopic): 329.0164 | AlogP: 3.66 | #Rotatable Bonds: 2 |
Polar Surface Area: 46.40 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.24 | CX LogP: 2.67 | CX LogD: 2.67 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.78 | Np Likeness Score: -2.41 |
References
1. Samala G, Nallangi R, Devi PB, Saxena S, Yadav R, Sridevi JP, Yogeeswari P, Sriram D.. (2014) Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors., 22 (15): [PMID:24953948] [10.1016/j.bmc.2014.05.038] |